Skip to content

Clinical trials

Phase 1/2 Biliary Tract Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Biliary Tract Neoplasms Phase: Phase 1/2 Country / region: France Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20201
20212
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting2
Terminated2
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Bolt Biotherapeutics, Inc.1
Bristol-Myers Squibb1
Cantargia AB1
Daiichi Sankyo1
Eli Lilly and Company1
Institut Bergonié1
Marengo Therapeutics, Inc.1
Servier Bio-Innovation LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Biliary Tract Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Colorectal Neoplasms6
Endometrial Neoplasms4
Stomach Neoplasms4
Carcinoma, Hepatocellular2
Carcinoma, Transitional Cell2
Esophageal Neoplasms2
Gastrointestinal Neoplasms2
Head and Neck Neoplasms2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.